ATE175213T1 - Ch0ndromodulin-ii protein - Google Patents

Ch0ndromodulin-ii protein

Info

Publication number
ATE175213T1
ATE175213T1 AT92113342T AT92113342T ATE175213T1 AT E175213 T1 ATE175213 T1 AT E175213T1 AT 92113342 T AT92113342 T AT 92113342T AT 92113342 T AT92113342 T AT 92113342T AT E175213 T1 ATE175213 T1 AT E175213T1
Authority
AT
Austria
Prior art keywords
protein
chondromodulin
chondrocytes
dalton
fgf
Prior art date
Application number
AT92113342T
Other languages
English (en)
Inventor
Fujio Suzuki
Yuji Hiraki
Jun Kondo
Akihito Kamizono
Hideho Tanaka
Yutaka Teranishi
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE175213T1 publication Critical patent/ATE175213T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92113342T 1991-08-05 1992-08-05 Ch0ndromodulin-ii protein ATE175213T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19549591 1991-08-05

Publications (1)

Publication Number Publication Date
ATE175213T1 true ATE175213T1 (de) 1999-01-15

Family

ID=16342039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92113342T ATE175213T1 (de) 1991-08-05 1992-08-05 Ch0ndromodulin-ii protein

Country Status (8)

Country Link
US (1) US5270303A (de)
EP (1) EP0526883B1 (de)
KR (1) KR930004326A (de)
AT (1) ATE175213T1 (de)
CA (1) CA2075240A1 (de)
DE (1) DE69228031T2 (de)
ES (1) ES2126580T3 (de)
TW (1) TW221692B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3637087B2 (ja) * 1994-11-28 2005-04-06 和男 鈴木 新規な白血球活性化因子
US6008013A (en) * 1996-07-05 1999-12-28 University Of Rochester Chondrocyte proteins
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
TWI323064B (en) 2006-09-01 2010-04-01 Compal Electronics Inc Power supplying system with remote-controlling circuit and method for operating a power supplying system
TWI472122B (zh) 2012-12-14 2015-02-01 遠翔科技股份有限公司 電流調節系統

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761471A (en) * 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4804744A (en) * 1984-01-04 1989-02-14 International Genetic Engineering, Inc. Osteogenic factors
US4877864A (en) * 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5106626A (en) * 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors

Also Published As

Publication number Publication date
DE69228031T2 (de) 1999-06-10
US5270303A (en) 1993-12-14
EP0526883B1 (de) 1998-12-30
DE69228031D1 (de) 1999-02-11
EP0526883A2 (de) 1993-02-10
EP0526883A3 (en) 1994-05-11
KR930004326A (ko) 1993-03-22
TW221692B (de) 1994-03-11
ES2126580T3 (es) 1999-04-01
CA2075240A1 (en) 1993-02-06

Similar Documents

Publication Publication Date Title
FI884604A0 (fi) Implanterbar, biologiskt nedbrytbart aktivmedels frigivningssystem.
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
ATE184009T1 (de) Halichondrine: zytotoxische polyäther-makrolide
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
NO895186L (no) Regulering av mikrobiell vekst med nisin/lysosym formuleringer.
DE69434997D1 (de) Menschliches Chondromodulin-I-Protein
DE68927759D1 (de) Cyclische Peptide mit Substance P-und Substance K-antagonistischer Aktivität
DE69228031D1 (de) Ch0ndromodulin-II Protein
IT1240683B (it) Composizione farmaceutica contenente egf
SE8902186L (sv) Nya polypeptider och deras anvaendning
ES2129022T3 (es) Proteina condromodulina-i.
DK0579939T3 (da) Phospholipidderivater
TW228524B (de)
ATE174911T1 (de) 1-dimethylcarbamoyl-1h-1,2,4-triazole- substituiert in stellungen 3 und 5
IL93721A0 (en) Mixed micelles compositions and their use as carriers for the parenteral application of the drugs
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
ZA901320B (en) Compositions for the treatment of microbial infections

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties